144 related articles for article (PubMed ID: 33402493)
1. Evaluation of Sodium (
Mohamed SA; Herrmann K; Adlung A; Paschke N; Hausner L; FrÖlich L; Schad L; Groden C; Kerl HU
In Vivo; 2021; 35(1):429-435. PubMed ID: 33402493
[TBL] [Abstract][Full Text] [Related]
2. 3T sodium MR imaging in Alzheimer's disease shows stage-dependent sodium increase influenced by age and local brain volume.
Haeger A; Boumezbeur F; Bottlaender M; Rabrait-Lerman C; Lagarde J; Mirzazade S; Krahe J; Hohenfeld C; Sarazin M; Schulz JB; Romanzetti S; Reetz K
Neuroimage Clin; 2022; 36():103274. PubMed ID: 36451374
[TBL] [Abstract][Full Text] [Related]
3. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).
Niemantsverdriet E; Ribbens A; Bastin C; Benoit F; Bergmans B; Bier JC; Bladt R; Claes L; De Deyn PP; Deryck O; Hanseeuw B; Ivanoiu A; Lemper JC; Mormont E; Picard G; Salmon E; Segers K; Sieben A; Smeets D; Struyfs H; Thiery E; Tournoy J; Triau E; Vanbinst AM; Versijpt J; Bjerke M; Engelborghs S
J Alzheimers Dis; 2018; 63(4):1509-1522. PubMed ID: 29782314
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's and vascular disease classification using regional texture biomarkers in FLAIR MRI.
Chan K; Fischer C; Maralani PJ; Black SE; Moody AR; Khademi A
Neuroimage Clin; 2023; 38():103385. PubMed ID: 36989851
[TBL] [Abstract][Full Text] [Related]
6. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.
Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J
Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and acceptance of simultaneous amyloid PET/MRI.
Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
Ota K; Oishi N; Ito K; Fukuyama H; ;
J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
[TBL] [Abstract][Full Text] [Related]
9. Characterizing white matter connectivity in Alzheimer's disease and mild cognitive impairment: An automated fiber quantification analysis with two independent datasets.
Dou X; Yao H; Feng F; Wang P; Zhou B; Jin D; Yang Z; Li J; Zhao C; Wang L; An N; Liu B; Zhang X; Liu Y
Cortex; 2020 Aug; 129():390-405. PubMed ID: 32574842
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
11. Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's Disease.
Cavedo E; Suppa P; Lange C; Opfer R; Lista S; Galluzzi S; Schwarz AJ; Spies L; Buchert R; Hampel H; ;
J Alzheimers Dis; 2017; 60(1):151-164. PubMed ID: 28777748
[TBL] [Abstract][Full Text] [Related]
12. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
[TBL] [Abstract][Full Text] [Related]
13. Application of advanced machine learning methods on resting-state fMRI network for identification of mild cognitive impairment and Alzheimer's disease.
Khazaee A; Ebrahimzadeh A; Babajani-Feremi A
Brain Imaging Behav; 2016 Sep; 10(3):799-817. PubMed ID: 26363784
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and prognosis of Alzheimer's disease using brain morphometry and white matter connectomes.
Wang Y; Xu C; Park JH; Lee S; Stern Y; Yoo S; Kim JH; Kim HS; Cha J;
Neuroimage Clin; 2019; 23():101859. PubMed ID: 31150957
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
[TBL] [Abstract][Full Text] [Related]
16. Automated atrophy assessment for Alzheimer's disease diagnosis from brain MRI images.
Shaikh TA; Ali R
Magn Reson Imaging; 2019 Oct; 62():167-173. PubMed ID: 31279772
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of Early Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Healthy Elderly Samples Using Multimodal Neuroimaging Indices.
Joshi H; Bharath S; Balachandar R; Sadanand S; Vishwakarma HV; Aiyappan S; Saini J; Kumar KJ; John JP; Varghese M
Brain Connect; 2019 Nov; 9(9):730-741. PubMed ID: 31389245
[TBL] [Abstract][Full Text] [Related]
18. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
19. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
